The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression

The Impact of the CYP2D6 and CYP1A2 Gene Polymorphisms on Response to Duloxetine in Patients with Major Depression

Depression is a global mental health concern, and personalized treatment approaches are needed to optimize its management. This study aimed to investigate the influence of the CYP2D6 and CYP1A2 gene polymorphisms on the efficacy of duloxetine in reducing depressive and anxiety symptoms. A sample of...

Full description

Bibliographic Details
Main Authors: Julian Maciaszek, Tomasz Pawłowski, Tomasz Hadryś, Marta Machowska, Anna Wiela-Hojeńska, Błażej Misiak
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:International Journal of Molecular Sciences
Subjects:
CYP2D6
CYP1A2
polymorphisms
duloxetine
tolerability
efficacy
Online Access:https://www.mdpi.com/1422-0067/24/17/13459

Internet

https://www.mdpi.com/1422-0067/24/17/13459

Similar Items